跳至主要内容
临床试验/NCT06435052
NCT06435052招募中不适用

Efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan: A Full-fledged Randomized Controlled Trial

Khushal Khan Khattak Univeristy, Karak, Pakistan2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
2
主要终点
Post-traumatic stress disorder

研究概览

简要总结

This Randomized Controlled Trial will check the efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan

详细描述

This Randomized Controlled Trial will check the efficacy of Eye Movement Desensitization & Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan.

It will be a single blind multi-center RCT with two arms (EMDR and CBT). This study will broadly work on following aims:

  1. Initially the comparative efficacy of EMDR and CBT (i.e., standard face-to-face protcols) will be determined on large scale in Pakistan by:

  2. Examining whether EMDR is non-inferior to CBT in the treatment of PTSD and its two comorbidities in Pakistan.

  3. Studying changes in the symptoms (i.e., reduction in the PTSD and comorbid symptoms with the passage of time) after administering EMDR and CBT. The level of change in the symptoms will ultimately help in determining the extent of effectiveness of both therapies.

  4. Examine the reciprocal relationship between PTSD and comorbid symptoms for knowing whether any reduction in the PTSD symptoms can help in reducing the comorbid symptoms after administering EMDR and CBT.

  5. At the mean time work on the design and development of virtual EMDR and CBT therapies (i.e., Web-based and Mobile Applications) will also be started. The initial prototypes will be tested for its comparative efficacy. Later once the final versions will be developed then it will be also tested for its comparative efficacy on large scale in Pakistan.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • reverse of the exclusion critera

排除标准

  • The following patients will be excluded:
  • Patients below the age of 15 years and above 60 years, since this study is neither on children nor on old aged patients;
  • Patients who can't move their hands and eyes/or can't perform basic movements;
  • Patients who are unconscious for longer periods and unable to recover consciousness;
  • Patients not meeting the basic screening criteria of PTSD/ PTSD is not the main problem;
  • Patients with severe intellectual impairments, since such patients are difficult to communicate

结局指标

主要结局

Post-traumatic stress disorder

时间窗: 2 years

Post-traumatic stress disorder (PTSD) will be assessed using the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). The CAPS-5 scores will be utilized to determine the severity of PTSD symptoms. Typically, a CAPS-5 score of 40 or above will serve as the cutoff point for diagnosing PTSD.

次要结局

  • Depressive and Anxiety Symptoms(2 years)

研究者

发起方
Khushal Khan Khattak Univeristy, Karak, Pakistan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Anwar Khan

Dr. Anwar Khan, Assistant Professor of Organizational Psychology

Khushal Khan Khattak Univeristy, Karak, Pakistan

研究点 (2)

Loading locations...

相似试验

Efficacy of Eye Movement Desensitization &... | 临床试验